Hyperthermia-driven aberrations of secreted microRNAs in breast cancer in vitro

References

• Romero-Cordoba SL, Salido-Guadarrama I, Rodriguez-Dorantes M, Hidalgo-Miranda A. miRNA biogenesis: biological impact in the development of cancer. Cancer biology & therapy. 2014;15(11):1444–55. doi: 10.4161/15384047.2014.955442.
   PubMed Web of Science ®Google Scholar
• Mulrane L, McGee SF, Gallagher WM, O'Connor DP. miRNA dysregulation in breast cancer. Cancer research. 2013;73(22):6554–62. doi: 10.1158/0008-5472.CAN-13-1841.
   PubMed Web of Science ®Google Scholar
• Bertoli G, Cava C, Castiglioni I. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer. Theranostics. 2015;5(10):1122–43. doi: 10.7150/thno.11543. PubMed PMID: 26199650; PubMed Central PMCID: PMC4508501.
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer science. 2010;101(10):2087–92. doi: 10.1111/j.1349-7006.2010.01650.x.
   PubMed Web of Science ®Google Scholar
• Huang YK, Yu JC. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review. World journal of gastroenterology. 2015;21(34):9863–86. doi: 10.3748/wjg.v21.i34.9863. PubMed PMID: 26379393; PubMed Central PMCID: PMC4566381.
   PubMed Web of Science ®Google Scholar
• Kosaka N, Ochiya T. Unraveling the Mystery of Cancer by Secretory microRNA: Horizontal microRNA Transfer between Living Cells. Frontiers in genetics. 2011;2(97):1–6. doi: 10.3389/fgene.2011.00097. PubMed PMID: 22303391; PubMed Central PMCID: PMC3262223.
   PubMedGoogle Scholar
• Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic acids research. 2011;39(16):7223–33. doi: 10.1093/nar/gkr254. PubMed PMID: 21609964; PubMed Central PMCID: PMC3167594.
   PubMed Web of Science ®Google Scholar
• Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(12):5003–8. doi: 10.1073/pnas.1019055108. PubMed PMID: 21383194; PubMed Central PMCID: PMC3064324.
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang S, Weber J, Baxter D, Galas DJ. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic acids research. 2010;38(20):7248–59. doi: 10.1093/nar/gkq601. PubMed PMID: 20615901; PubMed Central PMCID: PMC2978372.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li S, Li L, Li M, Guo C, Yao J, et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics, proteomics & bioinformatics. 2015;13(1):17–24. doi: 10.1016/j.gpb.2015.02.001. PubMed PMID: 25724326; PubMed Central PMCID: PMC4411500.
   PubMed Web of Science ®Google Scholar
• Cuk K, Zucknick M, Heil J, Madhavan D, Schott S, Turchinovich A, et al. Circulating microRNAs in plasma as early detection markers for breast cancer. International journal of cancer Journal international du cancer. 2013;132(7):1602–12. doi: 10.1002/ijc.27799.
   PubMed Web of Science ®Google Scholar
• Zhao FL, Hu GD, Wang XF, Zhang XH, Zhang YK, Yu ZS. Serum overexpression of microRNA-10b in patients with bone metastatic primary breast cancer. The Journal of international medical research. 2012;40(3):859–66.
   PubMed Web of Science ®Google Scholar
• Cortez MA, Welsh JW, Calin GA. Circulating microRNAs as noninvasive biomarkers in breast cancer. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer. 2012;195:151–61. doi: 10.1007/978-3-642-28160-0_13. PubMed PMID: 22527502; PubMed Central PMCID: PMC3855311.
   PubMedGoogle Scholar
• Redova M, Sana J, Slaby O. Circulating miRNAs as new blood-based biomarkers for solid cancers. Future oncology. 2013;9(3):387–402. doi: 10.2217/fon.12.192.
   PubMed Web of Science ®Google Scholar
• Schwarzenbach H. Circulating nucleic acids as biomarkers in breast cancer. Breast cancer research: BCR. 2013;15(5(211)):1–9. doi: 10.1186/bcr3446. PubMed PMID: 24090167; PubMed Central PMCID: PMC3978696.
   Web of Science ®Google Scholar
• Place RF, Noonan EJ. Non-coding RNAs turn up the heat: an emerging layer of novel regulators in the mammalian heat shock response. Cell stress & chaperones. 2014;19(2):159–72. doi: 10.1007/s12192-013-0456-5. PubMed PMID: 24002685; PubMed Central PMCID: PMC3933615.
   PubMed Web of Science ®Google Scholar
• Wilmink GJ, Roth CL, Ibey BL, Ketchum N, Bernhard J, Cerna CZ, et al. Identification of microRNAs associated with hyperthermia-induced cellular stress response. Cell stress & chaperones. 2010;15(6):1027–38. doi: 10.1007/s12192-010-0189-7. PubMed PMID: 20352393; PubMed Central PMCID: PMC3024070.
   PubMed Web of Science ®Google Scholar
• Zhang XL, Shi HJ, Wang JP, Tang HS, Wu YB, Fang ZY, et al. MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin. World journal of gastroenterology. 2014;20(32):11347–55. doi: 10.3748/wjg.v20.i32.11347. PubMed PMID: 25170221; PubMed Central PMCID: PMC4145775.
   PubMed Web of Science ®Google Scholar
• Manjili MH, Wang XY, Park J, Macdonald IJ, Li Y, Van Schie RC, et al. Cancer immunotherapy: stress proteins and hyperthermia. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2002;18(6):506–20. doi: 10.1080/02656730110116696.
   PubMed Web of Science ®Google Scholar
• Morey TM, Roufayel R, Johnston DS, Fletcher AS, Mosser DD. Heat shock inhibition of CDK5 increases NOXA levels through miR-23a repression. The Journal of biological chemistry. 2015;290(18):11443–54. doi: 10.1074/jbc.M114.625988. PubMed PMID: 25829494; PubMed Central PMCID: PMC4416849.
   PubMed Web of Science ®Google Scholar
• Ozgur A, Tutar L, Tutar Y. Regulation of Heat Shock Proteins by miRNAs in human breast cancer. MicroRNA. 2014;3(2):118–35.
   PubMedGoogle Scholar
• Diagnosis and treatment of patients with primary and metastatic breast cancer [Internet]. Comission Mamma, Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) e.V. 2014 [cited March 2014]. Available from: http://www.ago-online.de/fileadmin/downloads/leitlinien/mamma/maerz2014/AGO_Mamma_2014_en.zip.
   Google Scholar
• Oldenborg S, Van Os RM, Van rij CM, Crezee J, Van de Kamer JB, Rutgers EJ, et al. Elective re-irradiation and hyperthermia following resection of persistent locoregional recurrent breast cancer: A retrospective study. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2010;26(2):136–44. doi: 10.3109/02656730903341340.
   PubMed Web of Science ®Google Scholar
• Van Der Zee J, De Bruijne M, Mens JW, Ameziane A, Broekmeyer-Reurink MP, Drizdal T, et al. Reirradiation combined with hyperthermia in breast cancer recurrences: overview of experience in Erasmus MC. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2010;26(7):638–48. doi: 10.3109/02656736.2010.495104.
   PubMed Web of Science ®Google Scholar
• Vujaskovic Z, Kim DW, Jones E, Lan L, McCall L, Dewhirst MW, et al. A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2010;26(5):514–21. doi: 10.3109/02656731003639364. PubMed PMID: 20377362; PubMed Central PMCID: PMC2956498.
   PubMed Web of Science ®Google Scholar
• Zagar TM, Oleson JR, Vujaskovic Z, Dewhirst MW, Craciunescu OI, Blackwell KL, et al. Hyperthermia for locally advanced breast cancer. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2010;26(7):618–24. doi: 10.3109/02656736.2010.501051. PubMed PMID: 20849257; PubMed Central PMCID: PMC2949291.
   PubMed Web of Science ®Google Scholar
• Zagar TM, Oleson JR, Vujaskovic Z, Dewhirst MW, Craciunescu OI, Blackwell KL, et al. Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2010;26(7):612–7. doi: 10.3109/02656736.2010.487194. PubMed PMID: 20849256; PubMed Central PMCID: PMC2956421.
   PubMed Web of Science ®Google Scholar
• Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. International journal of radiation oncology, biology, physics. 1996;35(4):731–44.
   PubMed Web of Science ®Google Scholar
• Welz S, Hehr T, Lamprecht U, Scheithauer H, Budach W, Bamberg M. Thermoradiotherapy of the chest wall in locally advanced or recurrent breast cancer with marginal resection. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2005;21(2):159–67. doi: 10.1080/02656730400003393.
   PubMed Web of Science ®Google Scholar
• Li G, Mitsumori M, Ogura M, Horii N, Kawamura S, Masunaga S, et al. Local hyperthermia combined with external irradiation for regional recurrent breast carcinoma. International journal of clinical oncology. 2004;9(3):179–83. doi: 10.1007/s10147-004-0395-3.
   PubMedGoogle Scholar
• Linthorst M, Baaijens M, Wiggenraad R, Creutzberg C, Ghidey W, van Rhoon GC, et al. Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: Results in 248 patients. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2015;117(2):217–22. doi: 10.1016/j.radonc.2015.04.019.
   PubMed Web of Science ®Google Scholar
• Linthorst M, van Rhoon GC, van Geel AN, Baaijens M, Ghidey W, Broekmeyer-Reurink MP, et al. The tolerance of reirradiation and hyperthermia in breast cancer patients with reconstructions. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2012;28(3):267–77. doi: 10.3109/02656736.2012.663951.
   PubMed Web of Science ®Google Scholar
• Wang X, Cao L, Wang Y, Wang X, Liu N, You Y. Regulation of let-7 and its target oncogenes (Review). Oncology letters. 2012;3(5):955–60. doi: 10.3892/ol.2012.609. PubMed PMID: 22783372; PubMed Central PMCID: PMC3389667.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Deng C, Wang J, Xiao J, Gatalica Z, Recker RR, et al. Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer. Breast cancer research and treatment. 2011;127(1):69–80. doi: 10.1007/s10549-010-0972-2.
   PubMed Web of Science ®Google Scholar
• Sun X, Qin S, Fan C, Xu C, Du N, Ren H. Let-7: a regulator of the ERalpha signaling pathway in human breast tumors and breast cancer stem cells. Oncology reports. 2013;29(5):2079–87. doi: 10.3892/or.2013.2330.
   PubMed Web of Science ®Google Scholar
• Wu J, Li S, Jia W, Deng H, Chen K, Zhu L, et al. Reduced Let-7a Is Associated with Chemoresistance in Primary Breast Cancer. PloS one. 2015;10(7):e0133643. doi: 10.1371/journal.pone.0133643. PubMed PMID: 26218285; PubMed Central PMCID: PMC4517895.
   PubMedGoogle Scholar
• Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Annals of surgery. 2010;251(3):499–505. doi: 10.1097/SLA.0b013e3181cc939f.
   PubMed Web of Science ®Google Scholar
• Perez-Rivas LG, Jerez JM, Carmona R, de Luque V, Vicioso L, Claros MG, et al. A microRNA signature associated with early recurrence in breast cancer. PloS one. 2014;9(3):e91884. doi: 10.1371/journal.pone.0091884. PubMed PMID: 24632820; PubMed Central PMCID: PMC3954835.
   PubMedGoogle Scholar
• Hoppe R, Achinger-Kawecka J, Winter S, Fritz P, Lo WY, Schroth W, et al. Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment. European journal of cancer. 2013;49(17):3598–608. doi: 10.1016/j.ejca.2013.07.145.
   PubMed Web of Science ®Google Scholar
• Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007;449(7163):682–8. doi: 10.1038/nature06174.
   PubMed Web of Science ®Google Scholar
• Mar-Aguilar F, Mendoza-Ramirez JA, Malagon-Santiago I, Espino-Silva PK, Santuario-Facio SK, Ruiz-Flores P, et al. Serum circulating microRNA profiling for identification of potential breast cancer biomarkers. Disease markers. 2013;34(3):163–9. doi: 10.3233/DMA-120957. PubMed PMID: 23334650; PubMed Central PMCID: PMC3810231.
   PubMed Web of Science ®Google Scholar
• Taguchi YH, Murakami Y. Principal component analysis based feature extraction approach to identify circulating microRNA biomarkers. PloS one. 2013;8(6):e66714. doi: 10.1371/journal.pone.0066714. PubMed PMID: 23874370; PubMed Central PMCID: PMC3715582.
   PubMedGoogle Scholar
• Kedmi M, Ben-Chetrit N, Korner C, Mancini M, Ben-Moshe NB, Lauriola M, et al. EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer. Science signaling. 2015;8(368):ra29. doi: 10.1126/scisignal.2005866.
   PubMed Web of Science ®Google Scholar
• Fan Y, Yin S, Hao Y, Yang J, Zhang H, Sun C, et al. miR-19b promotes tumor growth and metastasis via targeting TP53. Rna. 2014;20(6):765–72. doi: 10.1261/rna.043026.113. PubMed PMID: 24742936; PubMed Central PMCID: PMC4024631.
   PubMed Web of Science ®Google Scholar
• Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, Thiruchelvam P, et al. The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(37):15732–7. doi: 10.1073/pnas.0906947106. PubMed PMID: 19706389; PubMed Central PMCID: PMC2747188.
   PubMed Web of Science ®Google Scholar
• Chen WX, Liu XM, Lv MM, Chen L, Zhao JH, Zhong SL, et al. Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PloS one. 2014;9(4):e95240. doi: 10.1371/journal.pone.0095240. PubMed PMID: 24740415; PubMed Central PMCID: PMC3989268.
   PubMed Web of Science ®Google Scholar
• Gebeshuber CA, Martinez J. miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling. Oncogene. 2013;32(27):3306–10. doi: 10.1038/onc.2012.372.
   PubMed Web of Science ®Google Scholar
• Yang Y, Xing Y, Liang C, Hu L, Xu F, Chen Y. Crucial microRNAs and genes of human primary breast cancer explored by microRNA-mRNA integrated analysis. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;36(7):5571–9. doi: 10.1007/s13277-015-3227-3.
   PubMed Web of Science ®Google Scholar
• Krishnan K, Steptoe AL, Martin HC, Pattabiraman DR, Nones K, Waddell N, et al. miR-139-5p is a regulator of metastatic pathways in breast cancer. Rna. 2013;19(12):1767–80. doi: 10.1261/rna.042143.113. PubMed PMID: 24158791; PubMed Central PMCID: PMC3884652.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li B, Zhao H, Chang J. The expression and clinical significance of serum miR-205 for breast cancer and its role in detection of human cancers. International journal of clinical and experimental medicine. 2015;8(2):3034–43. PubMed PMID: 25932280; PubMed Central PMCID: PMC4402927.
   PubMed Web of Science ®Google Scholar
• Shaker O, Maher M, Nassar Y, Morcos G, Gad Z. Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females. Gene. 2015;560(1):77–82. doi: 10.1016/j.gene.2015.01.062.
   PubMed Web of Science ®Google Scholar
• Bao L, Hazari S, Mehra S, Kaushal D, Moroz K, Dash S. Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298. The American journal of pathology. 2012;180(6):2490–503. doi: 10.1016/j.ajpath.2012.02.024. PubMed PMID: 22521303; PubMed Central PMCID: PMC3378910.
   PubMed Web of Science ®Google Scholar
• Giovannetti E, Erozenci A, Smit J, Danesi R, Peters GJ. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice. Critical reviews in oncology/hematology. 2012;81(2):103–22. doi: 10.1016/j.critrevonc.2011.03.010.
   PubMed Web of Science ®Google Scholar
• Magee P, Shi L, Garofalo M. Role of microRNAs in chemoresistance. Annals of translational medicine. 2015;3(21:332):1–9. doi: 10.3978/j.issn.2305-5839.2015.11.32. PubMed PMID: 26734642; PubMed Central PMCID: PMC4690999.
   PubMedGoogle Scholar
• Li J, Zhang Y, Zhao Q, Wang J, He X. MicroRNA-10a Influences Osteoblast Differentiation and Angiogenesis by Regulating beta-Catenin Expression. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology. 2015;37(6):2194–208. doi: 10.1159/000438576.
   PubMed Web of Science ®Google Scholar
• Yu T, Liu L, Li J, Yan M, Lin H, Liu Y, et al. MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN. Oncotarget. 2015;6(30):30239–50. doi: 10.18632/oncotarget.4972.
   PubMed Web of Science ®Google Scholar
• Ahmad A, Ginnebaugh KR, Yin S, Bollig-Fischer A, Reddy KB, Sarkar FH. Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4. BMC cancer. 2015;15:540. doi: 10.1186/s12885-015-1561-x. PubMed PMID: 26206152; PubMed Central PMCID: PMC4512090.
   PubMed Web of Science ®Google Scholar
• Fkih M'hamed I, Privat M, Ponelle F, Penault-Llorca F, Kenani A, Bignon YJ. Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers. Cellular oncology. 2015;38(6):433–42. doi: 10.1007/s13402-015-0239-3. PubMed PMID: 26392359; PubMed Central PMCID: PMC4653246.
   Web of Science ®Google Scholar
• Ma Z, Chen Y, Min L, Li L, Huang H, Li J, et al. Augmented miR-10b expression associated with depressed expression of its target gene KLF4 involved in gastric carcinoma. International journal of clinical and experimental pathology. 2015;8(5):5071–9. PubMed PMID: 26191201; PubMed Central PMCID: PMC4503073.
   PubMed Web of Science ®Google Scholar
• Yoo B, Kavishwar A, Ross A, Wang P, Tabassum DP, Polyak K, et al. Combining miR-10b-Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer. Cancer research. 2015;75(20):4407–15. doi: 10.1158/0008-5472.CAN-15-0888. PubMed PMID: 26359455; PubMed Central PMCID: PMC4609288.
   PubMed Web of Science ®Google Scholar
• Guo Y, Lang X, Lu Z, Wang J, Li T, Liao Y, et al. MiR-10b Directly Targets ZEB1 and PIK3CA to Curb Adenomyotic Epithelial Cell Invasiveness via Upregulation of E-Cadherin and Inhibition of Akt Phosphorylation. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology. 2015;35(6):2169–80. doi: 10.1159/000374022.
   PubMed Web of Science ®Google Scholar
• Jia Z, Wang K, Zhang A, Wang G, Kang C, Han L, et al. miR-19a and miR-19b overexpression in gliomas. Pathology oncology research: POR. 2013;19(4):847–53. doi: 10.1007/s12253-013-9653-x.
   PubMed Web of Science ®Google Scholar
• Jiang Q, He M, Guan S, Ma M, Wu H, Yu Z, et al. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/beta-catenin signaling pathway. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;37:5001–11. doi: 10.1007/s13277-015-4342-x.
   PubMed Web of Science ®Google Scholar
• Luan Y, Zhang S, Zuo L, Zhou L. Overexpression of miR-100 inhibits cell proliferation, migration, and chemosensitivity in human glioblastoma through FGFR3. OncoTargets and therapy. 2015;8:3391–400. doi: 10.2147/OTT.S85677. PubMed PMID: 26604796; PubMed Central PMCID: PMC4655956.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhao R, He Y, Fu X, Fu L, Zhu Z, et al. Micro RNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR. Oncotarget. 2015;7(5):5702–14. doi: 10.18632/oncotarget.6790.
   Web of Science ®Google Scholar
• Sun C, Sang M, Li S, Sun X, Yang C, Xi Y, et al. Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met. Oncotarget. 2015;6(37):39756–92. doi: 10.18632/oncotarget.5476.
   PubMed Web of Science ®Google Scholar
• Zhang HD, Sun DW, Mao L, Zhang J, Jiang LH, Li J, et al. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel. Biochemical and biophysical research communications. 2015;465(4):702–13. doi: 10.1016/j.bbrc.2015.08.053.
   PubMed Web of Science ®Google Scholar
• Li P, Xue WJ, Feng Y, Mao QS. MicroRNA-205 functions as a tumor suppressor in colorectal cancer by targeting cAMP responsive element binding protein 1 (CREB1). American journal of translational research. 2015;7(10):2053–9. PubMed PMID: 26692949; PubMed Central PMCID: PMC4656782.
   PubMed Web of Science ®Google Scholar
• Niu K, Shen W, Zhang Y, Zhao Y, Lu Y. MiR-205 promotes motility of ovarian cancer cells via targeting ZEB1. Gene. 2015;574(2):330–6. doi: 10.1016/j.gene.2015.08.017.
   PubMed Web of Science ®Google Scholar
• Yang G, Zhang P, Lv A, Liu Y, Wang G. MiR-205 functions as a tumor suppressor via targeting TGF-alpha in osteosarcoma. Experimental and molecular pathology. 2016;100(1):160–6. doi: 10.1016/j.yexmp.2015.12.010.
   PubMed Web of Science ®Google Scholar
• Zhang H, Fan Q. MicroRNA-205 inhibits the proliferation and invasion of breast cancer by regulating AMOT expression. Oncology reports. 2015;34(4):2163–70. doi: 10.3892/or.2015.4148.
   PubMed Web of Science ®Google Scholar
• Wu S, Huang S, Ding J, Zhao Y, Liang L, Liu T, et al. Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3' untranslated region. Oncogene. 2010;29(15):2302–8. doi: 10.1038/onc.2010.34.
   PubMed Web of Science ®Google Scholar
• Zhao H, Zhao D, Tan G, Liu Y, Zhuang L, Liu T. Bufalin promotes apoptosis of gastric cancer by down-regulation of miR-298 targeting bax. International journal of clinical and experimental medicine. 2015;8(3):3420–8. PubMed PMID: 26064232; PubMed Central PMCID: PMC4443066.
   PubMed Web of Science ®Google Scholar
• Garcia MP, Cavalheiro JR, Fernandes MH. Acute and long-term effects of hyperthermia in B16-F10 melanoma cells. PloS one. 2012;7(4):e35489: 1–9. doi: 10.1371/journal.pone.0035489. PubMed PMID: 22532856; PubMed Central PMCID: PMC3332049.
   Web of Science ®Google Scholar
• Habash RW, Bansal R, Krewski D, Alhafid HT. Thermal therapy, part 2: hyperthermia techniques. Critical reviews in biomedical engineering. 2006;34(6):491–542.
   PubMedGoogle Scholar
• Habash RW, Bansal R, Krewski D, Alhafid HT. Thermal therapy, part 1: an introduction to thermal therapy. Critical reviews in biomedical engineering. 2006;34(6):459–89.
   PubMedGoogle Scholar
• Heese C, Lavagnini P, Mills P, Lewis M, Markman M. Superficial Hyperthermia plus External Beam Radiation in the Palliation of Locally Progressive Chemoradiation-Resistant Breast Cancer. Case reports in oncology. 2012;5(3):520–3. doi: 10.1159/000343041. PubMed PMID: 23139665; PubMed Central PMCID: PMC3492962.
   PubMedGoogle Scholar
• Kampinga HH. Cell biological effects of hyperthermia alone or combined with radiation or drugs: a short introduction to newcomers in the field. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2006;22(3):191–6. doi: 10.1080/02656730500532028.
   PubMed Web of Science ®Google Scholar
• Larson N, Gormley A, Frazier N, Ghandehari H. Synergistic enhancement of cancer therapy using a combination of heat shock protein targeted HPMA copolymer-drug conjugates and gold nanorod induced hyperthermia. Journal of controlled release: official journal of the Controlled Release Society. 2013;170(1):41–50. doi: 10.1016/j.jconrel.2013.04.006. PubMed PMID: 23602864; PubMed Central PMCID: PMC3860371.
   PubMed Web of Science ®Google Scholar
• Baranzio GF, Hager ED. Hyperthermia In Cancer Treatment: A Primer. 2006;1:110–27. doi: 10.1007/978-0-387-33441-7.
   Google Scholar
• Toraya-Brown S, Fiering S. Local tumour hyperthermia as immunotherapy for metastatic cancer. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2014;30(8):531–9. doi: 10.3109/02656736.2014.968640. PubMed PMID: 25430985; PubMed Central PMCID: PMC4558619.
   PubMed Web of Science ®Google Scholar
• Triantopoulou S, Efstathopoulos E, Platoni K, Uzunoglou N, Kelekis N, Kouloulias V. Radiotherapy in conjunction with superficial and intracavitary hyperthermia for the treatment of solid tumors: survival and thermal parameters. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2013;15(2):95–105. doi: 10.1007/s12094-012-0947-3.
   PubMed Web of Science ®Google Scholar
• van der Zee J, de Bruijne M, van Rhoon GC. Thermal medicine, heat shock proteins and cancer. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2006;22(5):433–37; author reply 7-47. doi: 10.1080/02656730600768589.
   PubMed Web of Science ®Google Scholar
• Varkonyi-Gasic E, Hellens RP. Quantitative stem-loop RT-PCR for detection of microRNAs. Methods in molecular biology. 2011;744:145–57. doi: 10.1007/978-1-61779-123-9_10.
   PubMedGoogle Scholar
• Varkonyi-Gasic E, Wu R, Wood M, Walton EF, Hellens RP. Protocol: a highly sensitive RT-PCR method for detection and quantification of microRNAs. Plant methods. 2007;3(12):1–12. doi: 10.1186/1746-4811-3-12. PubMed PMID: 17931426; PubMed Central PMCID: PMC2225395.
   PubMed Web of Science ®Google Scholar
• Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper–Excel-based tool using pair-wise correlations. Biotechnology letters. 2004;26(6):509–15.
   PubMed Web of Science ®Google Scholar
• Chou CH, Chang NW, Shrestha S, Hsu SD, Lin YL, Lee WH, et al. miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic acids research. 2016;44(D1):D239–47. doi: 10.1093/nar/gkv1258. PubMed PMID: 26590260; PubMed Central PMCID: PMC4702890.
   PubMed Web of Science ®Google Scholar
• Fang JS, Gillies RD, Gatenby RA. Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Seminars in cancer biology. 2008;18(5):330–7. doi: 10.1016/j.semcancer.2008.03.011. PubMed PMID: 18455429; PubMed Central PMCID: PMC2953714.
   PubMed Web of Science ®Google Scholar
• Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nature reviews Cancer. 2004;4(11):891–9. doi: 10.1038/nrc1478.
   PubMed Web of Science ®Google Scholar
• Gatenby RA, Smallbone K, Maini PK, Rose F, Averill J, Nagle RB, et al. Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. British journal of cancer. 2007;97(5):646–53. doi: 10.1038/sj.bjc.6603922. PubMed PMID: 17687336; PubMed Central PMCID: PMC2360372.
   PubMed Web of Science ®Google Scholar
• Sameni M, Mullins SR, Moin K, Sloane BF, Osuala K. Importance of the Tumor Microenvironment. In: Ahmad A, editor. Breast Cancer Metastasis and Drug Resistance: Progress and Prospects. 1. 1 ed. New York: Springer; 2013. p. 178–9.
   Google Scholar
• Oshlag JZ, Devasthanam AS, Tomasi TB. Mild hyperthermia enhances the expression and induces oscillations in the Dicer protein. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2013;29(1):51–61. doi: 10.3109/02656736.2012.753471.
   PubMed Web of Science ®Google Scholar
• Yu J, Liu F, Yin P, Zhu X, Cheng G, Wang N, et al. Integrating miRNA and mRNA expression profiles in response to heat stress-induced injury in rat small intestine. Functional & integrative genomics. 2011;11(2):203–13. doi: 10.1007/s10142-010-0198-8.
   PubMed Web of Science ®Google Scholar
• Iwasaki S, Kobayashi M, Yoda M, Sakaguchi Y, Katsuma S, Suzuki T, et al. Hsc70/Hsp90 chaperone machinery mediates ATP-dependent RISC loading of small RNA duplexes. Molecular cell. 2010;39(2):292–9. doi: 10.1016/j.molcel.2010.05.015.
   PubMed Web of Science ®Google Scholar
• Lu YC, Chen YJ, Wang HM, Tsai CY, Chen WH, Huang YC, et al. Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling. Cancer prevention research. 2012;5(4):665–74. doi: 10.1158/1940-6207.CAPR-11-0358.
   PubMed Web of Science ®Google Scholar
• Han X, Yan S, Weijie Z, Feng W, Liuxing W, Mengquan L, et al. Critical role of miR-10b in transforming growth factor-beta1-induced epithelial-mesenchymal transition in breast cancer. Cancer gene therapy. 2014;21(2):60–7. doi: 10.1038/cgt.2013.82.
   PubMed Web of Science ®Google Scholar
• Singh R, Pochampally R, Watabe K, Lu Z, Mo YY. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Molecular cancer. 2014;13(256):1–11. doi: 10.1186/1476-4598-13-256. PubMed PMID: 25428807; PubMed Central PMCID: PMC4258287.
   PubMed Web of Science ®Google Scholar
• Finnerty JR, Wang WX, Hebert SS, Wilfred BR, Mao G, Nelson PT. The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. Journal of molecular biology. 2010;402(3):491–509. doi: 10.1016/j.jmb.2010.07.051. PubMed PMID: 20678503; PubMed Central PMCID: PMC2978331.
   PubMed Web of Science ®Google Scholar
• Gomez-Gomez Y, Organista-Nava J, Gariglio P. Deregulation of the miRNAs expression in cervical cancer: human papillomavirus implications. BioMed research international. 2013;2013:407052. doi: 10.1155/2013/407052. PubMed PMID: 24490161; PubMed Central PMCID: PMC3899709.
   PubMed Web of Science ®Google Scholar
• Rahman M, Lovat F, Romano G, Calore F, Acunzo M, Bell EH, et al. miR-15b/16-2 regulates factors that promote p53 phosphorylation and augments the DNA damage response following radiation in the lung. The Journal of biological chemistry. 2014;289(38):26406–16. doi: 10.1074/jbc.M114.573592. PubMed PMID: 25092292; PubMed Central PMCID: PMC4176210.
   PubMed Web of Science ®Google Scholar
• Sun G, Shi L, Yan S, Wan Z, Jiang N, Fu L, et al. MiR-15b targets cyclin D1 to regulate proliferation and apoptosis in glioma cells. BioMed research international. 2014;2014:687826. doi: 10.1155/2014/687826. PubMed PMID: 24995320; PubMed Central PMCID: PMC4065679.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Zhang L, Yao Q, Tao Z. miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells. Cancer gene therapy. 2015;22(3):108–14. doi: 10.1038/cgt.2014.73.
   PubMed Web of Science ®Google Scholar
• Zhang WL, Zhang JH, Wu XZ, Yan T, Lv W. miR-15b promotes epithelial-mesenchymal transition by inhibiting SMURF2 in pancreatic cancer. International journal of oncology. 2015;47(3):1043–53. doi: 10.3892/ijo.2015.3076.
   PubMed Web of Science ®Google Scholar
• Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. International journal of cancer Journal international du cancer. 2008;123(2):372–9. doi: 10.1002/ijc.23501.
   PubMed Web of Science ®Google Scholar
• Gu W, Li X, Wang J. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway. Oncology reports. 2014;31(1):397–404. doi: 10.3892/or.2013.2831.
   PubMed Web of Science ®Google Scholar
• Liu R, Yang M, Meng Y, Liao J, Sheng J, Pu Y, et al. Tumor-suppressive function of miR-139-5p in esophageal squamous cell carcinoma. PloS one. 2013;8(10):e77068. doi: 10.1371/journal.pone.0077068. PubMed PMID: 24204738; PubMed Central PMCID: PMC3799985.
   PubMedGoogle Scholar
• Xu W, Hang M, Yuan CY, Wu FL, Chen SB, Xue K. MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer. International journal of clinical and experimental pathology. 2015;8(4):3864–70. PubMed PMID: 26097570; PubMed Central PMCID: PMC4466957.
   PubMed Web of Science ®Google Scholar
• Zhang L, Dong Y, Zhu N, Tsoi H, Zhao Z, Wu CW, et al. microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer. Molecular cancer. 2014;13(124):1-12. doi: 10.1186/1476-4598-13-124. PubMed PMID: 24885920; PubMed Central PMCID: PMC4065091.
   Google Scholar
• Falcone G, Felsani A, D'Agnano I. Signaling by exosomal microRNAs in cancer. Journal of experimental & clinical cancer research: CR. 2015;34(32):1–10. doi: 10.1186/s13046-015-0148-3. PubMed PMID: 25886763; PubMed Central PMCID: PMC4391656.
   PubMed Web of Science ®Google Scholar